You may be eligible for a clinical trial examining a new non-invasive treatment to relieve pain caused by bone metastases or multiple myeloma.

An FDA-approved clinical trial is being conducted to test whether a non-invasive technology safely and effectively reduces pain from bone metastases. This outpatient procedure destroys the pain-causing nerves in the bone surface surrounding the tumor to relieve pain. 
This non-invasive technology is called Magnetic Resonance guided Focused Ultrasound (MRgFUS), and is being used on an ExAblate system. 

Download a patient pamphlet about the WIRB approved trial (PDF 300KB).

Russian                                       Hebrew